Avacta Group PLC (GB:AVCT)
LSE:AVCT

Avacta Group plc (AVCT) Stock Price & Analysis

5 Followers

AVCT Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range49.48p - 187.98p
Previous Close118p
Volume1.38M
Average Volume (3M)2.18M
Market Cap
389.50M
Enterprise Value30.41B
Total Cash (Recent Filing)£17.02M
Total Debt (Recent Filing)£4.83M
Price to Earnings (P/E)-13.5
Beta1.74
Apr 20, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding272,411,549
10 Day Avg. Volume2,367,481
30 Day Avg. Volume2,175,776
Standard Deviation0.48
R-Squared0.00718
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)8.51
Price to Sales (P/S)64.68
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-31.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

AVCT FAQ

What was Avacta Group PLC’s price range in the past 12 months?
Avacta Group PLC lowest stock price was 49.48p and its highest was 187.98p in the past 12 months.
    What is Avacta Group PLC’s market cap?
    Currently, no data Available
    When is Avacta Group PLC’s upcoming earnings report date?
    Avacta Group PLC’s upcoming earnings report date is Apr 20, 2023 which is in 23 days.
      How were Avacta Group PLC’s earnings last quarter?
      Avacta Group PLC released its earnings results on Sep 29, 2022. The company reported -0.036p earnings per share for the quarter, missing the consensus estimate of N/A by -0.036p.
        Is Avacta Group PLC overvalued?
        According to Wall Street analysts Avacta Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Avacta Group PLC pay dividends?
          Avacta Group PLC does not currently pay dividends.
          What is Avacta Group PLC’s EPS estimate?
          Avacta Group PLC’s EPS estimate is -0.05p.
            How many shares outstanding does Avacta Group PLC have?
            Avacta Group PLC has 272,411,560 shares outstanding.
              What happened to Avacta Group PLC’s price movement after its last earnings report?
              Avacta Group PLC reported an EPS of -0.036p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Avacta Group PLC?
                Currently, no hedge funds are holding shares in GB:AVCT

                ---

                Avacta Group plc Stock Smart Score

                9
                Outperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                122.71%
                12-Months-Change

                Fundamentals

                Return on Equity
                -56.29%
                Trailing 12-Months
                Asset Growth
                -24.62%
                Trailing 12-Months
                The Avacta Group plc Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Avacta Group PLC

                Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and preCISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Exscientia Plc
                COMPASS Pathways
                Centessa Pharmaceuticals
                Adaptimmune Therapeutics

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis